Factors influencing women's quality of life in the later half of life

Climacteric

Volumn 11, Issue 3, 2008, Pages 201-211

  Chiu, Y W ^a,b   Moore, R W ^b,c   Hsu, C E ^b,c   Huang, C T ^a   Liu, H W ^a   Chuang, H Y ^a,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Climacteric symptoms; Hormone replacement therapy; Path analysis; Quality of life; SF 36

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; MENOPAUSAL SYNDROME; MENOPAUSE; MENSTRUATION; MULTIPLE REGRESSION; OSTEOPOROSIS; PATH ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; STATISTICAL SIGNIFICANCE; TAIWAN;

ADULT; AFFECT; AGED; CLIMACTERIC; CROSS-SECTIONAL STUDIES; EMOTIONS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; TAIWAN; WOMEN'S HEALTH;

EID: 48249091298     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130801946779     Document Type: Article

References (38)

1. Zaydun G, Tomiyama H, Hashimoto H, et al. Menopause is an independent factor augmenting the age-related increase in arterial stiffness in the early postmenopausal phase. Atherosclerosis 2006;184:137-42
2. Khoo CL, Perera M. Diabetes and the menopause. J Br Menopause Soc 2005;11:6-11
3. La Vecchia C, Brinton LA, McTiernan A. Menopause, hormone replacement therapy and cancer. Maturitas 2001;39:97-115
4. Fuh JL, Wang SJ, Lee SJ, Lu SR, Juang KD. Quality of life and menopausal transition for middle-aged women on Kinmen island. Qual Life Res 2003;12:53-61
5. Limpaphayom KK, Darmasetiawan MS, Hussain RI, Burriss SW, Holinka CF, Ausmanas MK. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Climacteric 2006;9:204-14
6. World Health Organization. Research on the menopause in the 1990's. WHO Technical Report Series 866. Geneva, Switzerland: World Health Organization, 1996
7. Mansfield PK, Carey M, Anderson A, Barsom SH, Koch PB. Staging the menopausal transition: data from the TREMIN Research Program on Women's Health. Womens Health Issues 2004;14:220-6
8. World Health Organization Scientific Group. Research on the Menopause, WHO Technical Services Report Series 670. Geneva: World Health Organization, 1981
9. Kaufert P, Lock M, McKinlay S, et al. Menopause research: the Korpilampi workshop. Soc Sci Med 1986;22:1285-9
10. McKinlay SM. The normal menopause transition: an overview. Maturitas 1996;23:137-45
11. Genazzani AR, Nicolucci A, Campagnoli C, et al. Assessment of the QoL in Italian menopausal women: comparison between HRT users and non-users. Maturitas 2002;42:267-80
12. Ylikangas S, Sintonen H, Heikkinen J. Decade-long use of continuous combined hormone replacement therapy is associated with better health-related quality of life in postmenopausal women, as measured by the generic 15D instrument. J Br Menopause Soc 2005;11:145-51
13. Brunner RL, Gass M, Aragaki A, et al. Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial. Arch Intern Med 2005;165:1976-86
14. Avis NE, Assmann SF, Kravitz HM, Ganz PA, Ory M. Quality of life in diverse groups of midlife women: assessing the influence of menopause, health status and psychosocial and demographic factors. Qual Life Res 2004;13:933-46
15. Ho-Yin PL, Man-Wah P, Shing-Kai Y. Effects of aging on generic SF-36 quality of life measurements in Hong Kong Chinese women with urinary incontinence. Acta Obstet Gynecol Scand 2003;82:275-9
16. Ekstrom H, Hovelius B. Quality of life and hormone therapy in women before and after menopause. Scand J Prim Health Care 2000;18:115-21
17. Dennerstein L, Smith AM, Morse C. Psychological well-being, mid-life and the menopause. Maturitas 1994;20:1-11
18. Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-54
19. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33
20. Mishra G, Kok H, Ecob R, Cooper R, Hardy R, Kuh D. Cessation of hormone replacement therapy after reports of adverse findings from randomized controlled trials: evidence from a British birth cohort. Am J Public Health 2006;96:1219-25
21. Sumino H, Ichikawa S, Abe M, Endo Y, Ishikawa O, Kurabayashi M. Effects of aging, menopause, and hormone replacement therapy on forearm skin elasticity in women. J Am Geriatr Soc 2004;52:945-9
22. Brownley KA, Hinderliter AL, West SG, et al. Cardiovascular effects of 6 months of hormone replacement therapy versus placebo: differences associated with years since menopause. Am J Obstet Gynecol 2004;190:1052-8
23. Peeyananjarassri K, Baber R. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric 2005;8:13-23
24. Stevenson JC. Justification for the use of HRT in the long-term prevention of osteoporosis. Maturitas 2005;51:113-26
25. Newcomb PA, Longnecker MP, Storer BE, et al. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 1995;142:788-95
26. Ting JY, Chang AM. Path analysis modeling indicates free transport increases ambulance use for minor indications. Prehosp Emerg Care 2006;10:476-81
27. Audige L, Griffin D, Bhandari M, Kellam J, Ruedi TP. Path analysis of factors for delayed healing and nonunion in 416 operatively treated tibial shaft fractures. Clin Orthop Relat Res 2005;438:221-32
28. Cohen J, Cohen P, West SG, Aiken LS. Applied multiple regression/correlation analysis for the behavioral sciences. Mahweh, NJ: Laurence Ehlbaum, 2003: Ch 12
29. Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25-31
30. Steward AL, Ware JE. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press, 1992
31. McHorney CA, Ware JE, Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63
32. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83
33. SF-36 in Health Survey. Medical College of Wisconsin. Available from: http://www.mcw.edu/midas/health/SF-36.html. Accessed: May 1, 2007
34. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. The Health Institute, New England Medical Center, 1993
35. Database of cigarette smoking prevention. Bureau of Health Promotion, Department of Health. Available from: http://tobacco.bhp.doh.gov.tw:8080/. Accessed: September 29, 2007
36. Huang SJ. Review of epidemiological studies on smoking in Taiwan. Forum Health Promotion and Disease Prevention Committee. Taipei: National Health Research Institutes, 2000
37. Lombardi I, Jr, Oliveira LM, Monteiro CR, Confessor YQ, Barros TL, Natour J. Evaluation of physical capacity and quality of life in osteoporotic women. Osteoporos Int 2004;15:80-5
38. Silverman SL, Piziak VK, Chen P, Misurski DA, Wagman RB. Relationship of health related quality of life to prevalent and new or worsening back pain in postmenopausal women with osteoporosis. J Rheumatol 2005;32:2405-9